12 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology ProductsBranch Vein Occlusion, Embolism and Thrombosis, Venous Thrombosis, cardiovascular disorder, central retinal vein occlusion, diabetic macular edema, eye disorder, retinal disorder, retinal vein occlusion, thrombotic disease, vascular disorderActive, not recruitingNot stated2026-10-02NCT05476926
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, relapsing-remitting multiple sclerosisActive, not recruitingPhase 32026-09-28NCT04544436
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial DiseaseSkin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, arthritic joint disease, arthropathy, bone disorder, musculoskeletal system disorder, psoriasis, psoriatic arthritis, skin disorder, spondylitis, vertebral column disorderActive, not recruitingPhase 42026-09-25NCT04929210
Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR GeneX-Linked Retinitis PigmentosaActive, not recruitingPhase 32026-09-25NCT04794101
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMDNeovascular Age-related Macular DegenerationRecruitingPhase 32026-09-21NCT06847542
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorderActive, not recruitingPhase 32026-07-24NCT04548999
Amylin-Induced Migraine Attacks Without AuraHeadache, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorderNot yet recruitingNot applicable2026-01-14NCT07340788
Hypersensitivity to Amylin in Post-Traumatic HeadacheHeadache Disorders, Secondary, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Post-Traumatic Headache, Signs and Symptoms, brain disorder, central nervous system disorder, headache disorder, nervous system disorderNot yet recruitingNot applicable2026-01-14NCT07340775
Perineural Injections of Incobotulinumtoxin-A for Diabetic Neuropathic Pain of the Lower ExtremitiesDiabetes Complications, Diabetic Neuralgia, diabetes mellitus, diabetic neuropathy, endocrine system disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorderRecruitingPhase 22025-12-10NCT05623111
Induction of Migraine Attacks With Aura Using Calcitonin Gene-Related Peptidebrain disorder, central nervous system disorder, epilepsy, headache disorder, hypnic headache, migraine disorder, migraine with aura, nervous system disorderRecruitingNot applicable2025-08-06NCT07021859
Substance P-Induced Migraine Attacks Without AuraHeadache, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorderRecruitingNot applicable2025-06-05NCT06959004
Danish Angle Closure Prevention TrialPrimary Angle Glaucoma Closure SuspectRecruitingNot applicable2023-11-13NCT06077253